CollPlant Biotechnologies (NASDAQ: CLGN), a regenerative and aesthetics medicine company developing innovative technologies ...

One-size-fits-all hats are okay, but one-size-fits-all medical treatments don't cut it. A new study shows that drug treatment ...

On a recent "Mesirow Monday" radio appearance on WGN's "Your Money Matters" with Jon Hansen, Mesirow Advanced Planning Specialist and Wealth Advisor Gary Pattengale, CFP® outlined the strategic ...

In the frigid, dark depths of the Arctic Ocean and North Atlantic waters, a remarkable creature silently glides through the ...

Gut bacteria changes could be ‘warning sign for worsening Parkinson’s symptoms’ - Scientists suggest the toxins could one day ...

This particular Dollar Tree at 1549 NE 145th St has achieved something of a legendary status among bargain hunters in the Emerald City. It’s where Washingtonians with champagne dreams but beer budgets ...

A team of biomedical researchers led by Michael Mak, Ph.D., in the Renaissance School of Medicine at Stony Brook University, ...

Tel Aviv University researchers say neutrophils can be late-stage breast cancer target and biomarker; Beilinson Hospital ...

The new method is essentially a novel platform technology that can be used to print wide-ranging tissue and organ types.

NCoR1/RARα interaction was identified as a target for selective chaperone-mediated autophagy (CMA) inhibition in lung cancer.

Know about the BITSAT syllabus in detail. Check the subject-wise topics, weightage, prep tips, best books on this page.